Mosaic Therapeutics appoints Dr Barry Davies as CSO

There are nine Hu­mi­ra biosim­i­lars cur­rent­ly vy­ing to de­throne the best-sell­ing drug of all-time. And so far, none of them are com­ing any­where close. As

Patients with inflammatory bowel disease (IBD) were 13% more likely to suffer a stroke than the general population, even decades after their diagnosis, according to